|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,768.30 INR | +2.29% |
|
+5.58% | +23.85% |
| Market Cap | 1,613B 16.94B 14.81B 13.61B 12.69B 24.06B 24.43B 163B 63.51B 793B 63.58B 62.22B 2,732B | P/E 2027 * |
68.7x | P/E 2028 * | 50.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1,726B 18.13B 15.85B 14.57B 13.58B 25.75B 26.14B 175B 67.98B 849B 68.06B 66.6B 2,924B | EV / Sales 2027 * |
9.12x | EV / Sales 2028 * | 7.97x |
| Free-Float |
28.81% | Yield 2027 * |
0.68% | Yield 2028 * | 0.76% |
Last Transcript: Torrent Pharmaceuticals Limited
| 1 day | +2.29% | ||
| 1 week | +5.58% | ||
| Current month | +3.21% | ||
| 1 month | +9.87% | ||
| 3 months | +19.59% | ||
| 6 months | +22.73% | ||
| Current year | +23.85% |
| 1 week | 4,506.1 |  | 4,783 |
| 1 month | 4,350 | | 4,783 |
| Current year | 3,695 | | 4,783 |
| 1 year | 3,295.3 | | 4,783 |
| 3 years | 1,772.05 | | 4,783 |
| 5 years | 1,242.08 | | 4,783 |
| 10 years | 570.98 | | 4,783 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 2025-07-31 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 2018-08-31 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 2014-07-29 | |
| Director/Board Member | 46 | 2018-02-07 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 2019-03-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | +5.58% | - | - | 16.94B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +2.12% | +4.58% | +31.00% | +57.82% | 410.27B | |
| Weighted average by Cap. | +2.25% | +5.53% | +41.78% | +83.01% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 189B 1.99B 1.74B 1.6B 1.49B 2.82B 2.87B 19.18B 7.46B 93.08B 7.46B 7.3B 321B | 213B 2.23B 1.95B 1.79B 1.67B 3.17B 3.22B 21.53B 8.37B 104B 8.38B 8.2B 360B |
| Net income | 24.74B 260M 227M 209M 195M 369M 375M 2.51B 974M 12.16B 975M 954M 41.9B | 33.9B 356M 311M 286M 267M 506M 513M 3.43B 1.33B 16.66B 1.34B 1.31B 57.42B |
| Net Debt | 113B 1.19B 1.04B 957M 892M 1.69B 1.72B 11.49B 4.47B 55.78B 4.47B 4.38B 192B | 82.04B 862M 753M 692M 645M 1.22B 1.24B 8.31B 3.23B 40.33B 3.23B 3.16B 139B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹4,768.30 | +2.29% | 345,920 |
| 26-07-02 | ₹4,661.40 | +0.44% | 227,461 |
| 26-07-01 | ₹4,640.80 | +0.45% | 200,344 |
| 26-06-30 | ₹4,620.10 | -0.81% | 466,117 |
| 26-06-29 | ₹4,657.60 | +3.13% | 2,069,992 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
- TORNTPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
